Effectiveness and Safety of Intensive Triplet Chemotherapy Plus Bevacizumab, FIr-BFOx, in Young-Elderly Metastatic Colorectal Cancer Patients
Joint Authors
Ficorella, Corrado
Giordano, Aldo Victor
Cannita, Katia
Bruera, Gemma
Vicentini, Roberto
Ricevuto, Enrico
Source
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-9, 9 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-11-06
Country of Publication
Egypt
No. of Pages
9
Main Subjects
Abstract EN
Four-drug regimens, such as FIr-B/FOx schedule, can improve efficacy of first-line treatment of metastatic colorectal cancer (MCRC) patients.
The present study specifically evaluates feasibility of FIr-B/FOx first-line intensive regimen in fit young-elderly MCRC patients, representing approximately 40% of overall MCRC patients.
Activity, efficacy, and safety were equivalent to overall MCRC patients, not significantly different according to KRAS genotype.
Clinical outcome was significantly prolonged in liver-limited compared to other/multiple metastatic disease.
Safety evaluation of the individual young-elderly patient showed that limiting toxicity syndromes (LTS) in multiple sites were significantly increased, compared to LTS in single site, with respect to non-elderly patients.
American Psychological Association (APA)
Bruera, Gemma& Cannita, Katia& Giordano, Aldo Victor& Vicentini, Roberto& Ficorella, Corrado& Ricevuto, Enrico. 2013. Effectiveness and Safety of Intensive Triplet Chemotherapy Plus Bevacizumab, FIr-BFOx, in Young-Elderly Metastatic Colorectal Cancer Patients. BioMed Research International،Vol. 2013, no. 2013, pp.1-9.
https://search.emarefa.net/detail/BIM-1030110
Modern Language Association (MLA)
Bruera, Gemma…[et al.]. Effectiveness and Safety of Intensive Triplet Chemotherapy Plus Bevacizumab, FIr-BFOx, in Young-Elderly Metastatic Colorectal Cancer Patients. BioMed Research International No. 2013 (2013), pp.1-9.
https://search.emarefa.net/detail/BIM-1030110
American Medical Association (AMA)
Bruera, Gemma& Cannita, Katia& Giordano, Aldo Victor& Vicentini, Roberto& Ficorella, Corrado& Ricevuto, Enrico. Effectiveness and Safety of Intensive Triplet Chemotherapy Plus Bevacizumab, FIr-BFOx, in Young-Elderly Metastatic Colorectal Cancer Patients. BioMed Research International. 2013. Vol. 2013, no. 2013, pp.1-9.
https://search.emarefa.net/detail/BIM-1030110
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1030110